BioLineRx Ltd. (BLRX) Debt to Equity Ratio
BioLineRx Ltd. (BLRX) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2017-12-31 | 0.01 |
| 2018-12-31 | 0.23 |
| 2019-12-31 | 0.34 |
| 2020-12-31 | 11.03 |
| 2021-12-31 | 0.13 |
| 2022-12-31 | 0.06 |
| 2023-12-31 | 0.74 |
| 2024-12-31 | 0.70 |
Debt to equity divides total borrowings by total shareholder equity at the period end. Total borrowings are short-term debt plus long-term debt, including capital lease obligations. Non-debt liabilities such as accounts payable and deferred revenue are excluded. A period is omitted when equity is negative, because the ratio is not meaningful then.
Get BioLineRx Ltd. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("BLRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BLRX | $3.02 | +7.58% | 0.00M |
| 3 | ||||
| 4 | ||||
| 5 |